•
Dec 31, 2023
•
/

Ascendis Pharma Q4 2023 Earnings Report

Total Revenue
€134M
Previous year: €21.8M
+513.6%
EPS
-€1.5
Previous year: -€3.53
-57.5%
Gross Profit
€110M
Cash and Equivalents
€399M
Free Cash Flow
-€35.8M
Total Assets
€825M

Ascendis Pharma

Ascendis Pharma